(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6 Assay 98.0~102.0% (HPLC) Factory
Ruifu Chemical Supply Lansoprazole Intermediates
Lansoprazole CAS 103577-45-3
Lansoprazole Chloride Compound CAS 127337-60-4
(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6
Chemical Name | (R)-Lansoprazole |
Mashoko anoreva zvakafanana | R-(+)-Lansoprazole;Dexlansoprazole;2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;T 168390;TAK 390;Lansoprazole Kusachena 14;Dexlansoprazole Yakabatana Nekusvibiswa 2;(R) -2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-Benzimidazole; |
Nhamba yeCAS | 138530-94-6 |
Nhamba yeCAT | RF-PI1916 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C16H14F3N3O2S |
Molecular Weight | 369.36 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Crystalline Powder |
Solubility | Soluble muDimethylformamide, Inenge isingasviki mumvura |
Kujeka & Rudzi rweSolution | Zvinozadzisa Zvinodiwa |
Kuzivikanwa IR | Iyo infrared absorption spectrum inofanirwa kuenderana nereferensi chinhu |
Kuzivikanwa HPLC | Nguva yekuchengeta yenhongonya huru inofanirwa kuenderana neyereferensi |
Specific Rotation | +142.0°~+149.0° |
Melting Point | ~140.0℃ |
Zvemumvura (KF) | <1.00% |
Residue paIgnition | <0.10% |
Kusachena kwakabatana | (HPLC) |
Nitrogen Oxides | <0.10% |
Sulfone | <0.40% |
Sulfidi | <0.20% |
Chero Kumwe Kusachena Kumwechete | <0.10% |
Zvose Zvisina Kuchena | <0.60% |
Optical Purity (HPLC) | >99.5% |
Assay | 98.0~102.0% (HPLC, %w/w, pane anhydrous basis, solvent-isina) |
Heavy Metals | <10ppm |
Residual Solvents | |
Toluene | <890ppm |
n-Heptane | <5000ppm |
Bacterial Endotoxin | <2.5EU/mg |
Test Standard | USP Standard;Chinese Pharmacopoeia |
Usage | API;An Olly Active Proton Pump Inhibitor |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
(R) -Lansoprazole (CAS: 138530-94-6) ndiyo R enantiomer yeLansoprazole, Lansoprazole (AG 1749) inonzi proton pump inhibitor inoshandiswa nemuromo inodzivirira dumbu kubva pakubudisa asidi.Dexlansoprazole yeLansoprazole dextroisomer, imhando yemishonga inorwisa peptic ulcer inotsiviwa nebenzimidazole derivatives, mune molecular chimiro mu element fluorine, yechipiri proton pump inhibitors omeprazole mushure.Dexlansoprazole ine mhedzisiro yekudzivisa kuvharwa kwegastric acid, mhedzisiro yacho iri nani pane yemamwe madhiragi (Omeprazole, Pantoprazole, Rebela, Tetrazolium) inogona kuvharisa zvakanyanya kuitika kwemaronda.Iyo yepamusoro kune famotidine kana Omeprazole yekukuvadzwa kwedoro induced gastric mucosa uye duodenal ulcer inonyanya kukonzerwa ne acid hypersecretion.Uye zvakare, chigadzirwa chine imwechete anti Helicobacter pylori mhedzisiro sekugadzirira bismuth, uye inoshandiswa kune reflux esophagitis uye Zhuo AI syndrome.Takeda Pharmaceuticals yakagamuchira mvumo ye dexlansoprazole, kaviri kusunungurwa kugadzirwa kwe (R) -isomer ye lansoprazol proton pump inhibitor (PPI) yatova mumusika, kubva kuFDA muna Ndira 2009. Dexlansoprazole inguva yakanonoka kuburitsa kapule yekurapwa kamwe chete pazuva, nemumuromo. yekupisa kwemoyo kunoenderana nechiratidzo chisiri-erosive gastroesophageal reflux chirwere (GERD), kuporeswa kweerosive esophagitis (EE) uye kuchengetedzwa kweEE yakaporeswa.